{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:45:37Z","timestamp":1793357137372,"version":"4.5.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008958","name":"Lawson Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012118","name":"Ontario Institute for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012118","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Collaborative Research Program","award":["BX2019100"],"award-info":[{"award-number":["BX2019100"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["169650"],"award-info":[{"award-number":["169650"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Hyperglycemia-induced transcriptional alterations lead to aberrant synthesis of a large number of pathogenetic molecules leading to functional and structural damage to multiple end organs including the kidneys. Diabetic nephropathy (DN) remains a major cause of end stage renal disease. Multiple epigenetic mechanisms, including alteration of long non-coding RNAs (lncRNAs) may play a significant role mediating the cellular transcriptional activities. We have previously shown that lncRNA ANRIL may mediate diabetes associated molecular, functional and structural abnormalities in DN. Here we explored downstream mechanisms of ANRIL alteration in DN.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We used renal cortical tissues from ANRIL knockout (KO) mice and wild type (WT) mice, with or without streptozotocin (STZ) induced diabetes for RNA sequencing. The differentially expressed genes were identified using edgeR and DESeq2 computational methods. KEGG and Reactome pathway analyses and network analyses using STRING and IPA were subsequently performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Diabetic animals showed hyperglycemia, reduced body weight gain, polyuria and increased urinary albumin. Both albuminuria and polyuria were corrected in the KO diabetic mice. RNA analyses showed Diabetes induced alterations of a large number of transcripts in the wild type (WT) animals. ANRIL knockout (KO) prevented a large number of such alterations. The altered transcripts include metabolic pathways, apoptosis, extracellular matrix protein synthesis and degradation, NFKB related pathways, AGE-RAGE interaction pathways etc. ANRIL KO prevented majority of these pathways.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>These findings suggest that as ANRIL regulates a large number of molecules of pathogenetic significance, it may potentially be a drug target for DN and other chronic diabetic complications.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270287","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T17:37:27Z","timestamp":1660930647000},"page":"e0270287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["ANRIL regulates multiple molecules of pathogenetic significance in diabetic nephropathy"],"prefix":"10.1371","volume":"17","author":[{"given":"Parisa","family":"Sooshtari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoliang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-1401","authenticated-orcid":true,"given":"Subrata","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"7","key":"pone.0270287.ref001","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dom.12630","article-title":"Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?","volume":"18","author":"H Gallagher","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"pone.0270287.ref002","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: Challenges, Progress, and Possibilities","volume":"12","author":"RZ Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0270287.ref003","first-page":"28","article-title":"Diabetes and end-stage renal disease; a review article on new concepts","volume":"4","author":"SB Ghaderian","year":"2015","journal-title":"J Renal Inj Prev"},{"issue":"5","key":"pone.0270287.ref004","doi-asserted-by":"crossref","first-page":"e96987","DOI":"10.1371\/journal.pone.0096987","article-title":"Transcriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment","volume":"9","author":"R Komers","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"pone.0270287.ref005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0002-9440(10)64066-7","article-title":"Glucose, VEGF-A, and diabetic complications","volume":"158","author":"LE Benjamin","year":"2001","journal-title":"Am J Pathol"},{"issue":"3\u20134","key":"pone.0270287.ref006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004670000461","article-title":"Molecular basis of renal fibrosis","volume":"15","author":"AA Eddy","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"pone.0270287.ref007","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"A Portela","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"3","key":"pone.0270287.ref008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11892-016-0723-9","article-title":"Epigenetic Mechanisms in Diabetic Kidney Disease","volume":"16","author":"MC Thomas","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"6","key":"pone.0270287.ref009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","article-title":"Long noncoding RNAs and human disease","volume":"21","author":"O Wapinski","year":"2011","journal-title":"Trends Cell Biol"},{"key":"pone.0270287.ref010","first-page":"29","article-title":"Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease","volume":"394","author":"F Aguilo","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"pone.0270287.ref011","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms14011278","article-title":"ANRIL: molecular mechanisms and implications in human health","volume":"14","author":"A Congrains","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0270287.ref012","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1167\/iovs.16-20569","article-title":"ANRIL: A Regulator of VEGF in Diabetic Retinopathy","volume":"58","author":"AA Thomas","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"pone.0270287.ref013","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00268.2017","article-title":"ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications","volume":"314","author":"AA Thomas","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"pone.0270287.ref014","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cellsig.2013.02.006","article-title":"Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway","volume":"25","author":"G Wan","year":"2013","journal-title":"Cell Signal"},{"issue":"7287","key":"pone.0270287.ref015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"A Visel","year":"2010","journal-title":"Nature"},{"issue":"4","key":"pone.0270287.ref016","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/dmrr.2279","article-title":"Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats","volume":"28","author":"C Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"pone.0270287.ref017","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/db15-1033","article-title":"miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy","volume":"65","author":"B Feng","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"pone.0270287.ref018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2013.12.199","article-title":"miRNA-1 regulates endothelin-1 in diabetes","volume":"98","author":"B Feng","year":"2014","journal-title":"Life Sci"},{"issue":"1","key":"pone.0270287.ref019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"A Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"8","key":"pone.0270287.ref020","doi-asserted-by":"crossref","first-page":"e1003118","DOI":"10.1371\/journal.pcbi.1003118","article-title":"Software for computing and annotating genomic ranges","volume":"9","author":"M Lawrence","year":"2013","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"pone.0270287.ref021","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"pone.0270287.ref022","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"MD Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"1","key":"pone.0270287.ref023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"pone.0270287.ref024","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"M. Kanehisa","year":"2019","journal-title":"Protein Sci"},{"issue":"D1","key":"pone.0270287.ref025","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"M Kanehisa","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"pone.0270287.ref026","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"B Jassal","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0270287.ref027","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","article-title":"Epigenetics and epigenomics in diabetic kidney disease and metabolic memory","volume":"15","author":"M Kato","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"pone.0270287.ref028","doi-asserted-by":"crossref","first-page":"118728","DOI":"10.1016\/j.lfs.2020.118728","article-title":"LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497\/thioredoxin-interacting protein axis in diabetic nephropathy","volume":"264","author":"J Wang","year":"2021","journal-title":"Life Sci"},{"key":"pone.0270287.ref029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fcvm.2018.00047","article-title":"Roles of the Chr.9p21.3 ANRIL Locus in Regulating Inflammation and Implications for Anti-Inflammatory Drug Target Identification","volume":"5","author":"G Aarabi","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"pone.0270287.ref030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/16078454.2021.1872275","article-title":"Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma","volume":"26","author":"Y Yin","year":"2021","journal-title":"Hematology"},{"key":"pone.0270287.ref031","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.12659\/MSM.913265","article-title":"Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis","volume":"25","author":"A Regmi","year":"2019","journal-title":"Med Sci Monit"},{"key":"pone.0270287.ref032","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12935-020-01185-z","article-title":"MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma","volume":"20","author":"C Dai","year":"2020","journal-title":"Cancer Cell Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T17:38:02Z","timestamp":1660930682000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270287"}},"subtitle":[],"editor":[{"given":"Rajakumar","family":"Anbazhagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}